產品系列 / 解決方案: CLIA Immunoassay Solutions

GBC CL i120 CLIA System

Product Information Download

Download GBC CL i120 Brochure (PDF)Download

SPECIFICATION

Dimensions430 (L) × 680 (W) × 620 (H) mm
Weight Net weight62 kg
Power voltage100V-240V～，50Hz/60Hz , 850VA
Ambient temperature10℃～30℃
Relative humidity≤85%，no condensation.
Sample typeHuman serum, plasma, whole blood, urine samples
PrincipleEnzymatic chemiluminescence or direct CLIA (AE)
Throughput120 tests/hour (max)
Time to First Result≤ 15 min
Sample position10 pcs
Sample position30 pcs
Solid Waste200 assay cups per container
Reagent refrigeration at reagent diskRefrigeration with a temperature of 2°C~8°C
Temperature stability37℃± 0.3℃
Liquid level detectionSupport
CertificationTFDA

PRODUCT INFORMATION

It is the fully automatic chemiluminescence analyzer, with below features.

ORDERING INFORMATION

Catalogue No.Product
4MGCLI120Chemiluminescence Analyzer  GBC CL i120

GB CL TSH

PRODUCT DESCRIPTION

This reagent is an in-vitro diagnostic quantitative assay, using chemiluminescent immunoassay (CLIA) sandwich format, for measuring human TSH in serum or plasma. It requires 80 µL sample volume and delivers results in 20 minutes. With a detection limit of 0.015 µIU/mL, it detects very low TSH concentrations. Stored at 2-8°C, avoid light exposure and freezing. Ideal for diagnosing primary, pituitary, or hypothalamic causes of thyroid dysfunction and monitoring recovery or therapy.

PERFORMANCE

Limit of Quantitation (LoQ): 0.015 μIU/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time20 minutes
Sample typeSerum/Plasma
Sample volume80 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4ATSH02GB CL TSH
4ATSH1BGB CL TSH-Control
4ATSH2BGB CL TSH-Calibrator

GB CL CEA

PRODUCT DESCRIPTION

This in vitro diagnostic kit uses a quantitative chemiluminescent immunoassay (CL) sandwich format to measure carcinoembryonic antigen (CEA) in human serum or plasma. Requires 30 µL sample, with a rapid 10-minute assay. LoQ is 0.32 ng/mL. Stored at 2-8°C, protected from light. TFDA certified. Ideal for colorectal cancer diagnostics and monitoring disease progression or recurrence.

PERFORMANCE

Limit of Quantitation (LoQ): 0.32 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume30 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4ACEA02GB CL CEA
4ACEA1BGB CL CEA-Control
4ACEA2BGB CL CEA-Calibrator

GB CL FT4

PRODUCT DESCRIPTION

This in vitro diagnostic quantitative reagent kit uses a competitive chemiluminescent immunoassay (CLIA) to measure free thyroxine (Free T4) in human serum or plasma. It requires 30 µL of specimen and features a 30-minute assay time. The analytical limit of quantification (LoQ) is 3.00 pmol/L. Precision is high: repeatability, reproducibility, and variation across locations/operators/batches all show CV <10%. The reagent is stored at 2-8°C, protected from light and not frozen. Certified under Taiwan FDA. Ideal for clinical thyroid function assessment and supportive diagnosis.

PERFORMANCE

Limit of Quantitation (LoQ): 3.00 pmol/L
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleCompetition-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time30 minutes
Sample typeSerum/Plasma
Sample volume30 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4AFT402GB CL FT4
4AFT41BGB CL FT4-Control
4AFT42BGB CL FT4-Calibrator

GB CL FT3

PRODUCT DESCRIPTION

This in vitro diagnostic quantitative reagent kit uses a competitive chemiluminescent immunoassay format to measure free triiodothyronine (Free T3) in human serum or plasma. It requires a 30 µL sample, a 30-minute assay, and has a limit of quantification (LoQ) of 0.77 pmol/L. Stored at 2-8°C, protected from direct sunlight and not frozen. TFDA certified. Ideal for evaluating thyroid function and managing metabolic or endocrine disorders.

PERFORMANCE

Limit of Quantitation (LoQ): 0.77 pmol/L
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleCompetition-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time30 minutes
Sample typeSerum/Plasma
Sample volume30 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4AFT302GB CL FT3
4AFT31BGB CL FT3-Control
4AFT32BGB CL FT3-Calibrator

GB CL PSA

PRODUCT DESCRIPTION

This in vitro diagnostic kit uses a chemiluminescent immunoassay with magnetic microparticles and a sandwich format to quantitatively measure total PSA in human serum or plasma. Requires 50 µL sample and delivers results in 10 minutes. Limit of quantification is 0.029 ng/mL. Storage at 2-8°C; avoid direct sunlight and freezing. CE certified. Ideal for early prostate disease detection, screening, and monitoring disease progression or therapy response.

PERFORMANCE

Limit of Quantitation (LoQ): 0.029 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume50 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4APSA02GB CL PSA
4APSA1BGB CL PSA-Control
4APSA2BGB CL PSA-Calibrator

GB CL AFP

PRODUCT DESCRIPTION

This reagent is an in vitro diagnostic quantitative assay using a sandwich chemiluminescent immunoassay (CL) to measure Alpha-fetoprotein (AFP) in human serum or plasma. It requires only 5 µL sample and delivers results in about 10 minutes. The limit of quantification (LoQ) is 1.6 ng/mL. Stored at 2-8°C; avoid direct sunlight and do not freeze. Suitable for detection and monitoring of hepatocellular carcinoma (HCC) and germ cell tumors.

PERFORMANCE

Limit of Quantitation (LoQ): 1.6 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume5 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationRUO

ORDERING INFORMATION

Catalogue No.Product
4AAFP02GB CL AFP
4AAFP1BGB CL AFP-Control
4AAFP2BGB CL AFP-Calibrator

GB CL SCC

PRODUCT DESCRIPTION

This in vitro diagnostic quantitative CL reagent uses the sandwich chemiluminescent immunoassay format to measure squamous cell carcinoma antigen (SCCA) in human serum or plasma. It requires 20 µL specimen and provides results in about 10 minutes. LoQ is 0.28 ng/mL. Stored at 2-8°C, avoid direct sunlight and freezing. TFDA certified. Useful for detection and monitoring of squamous cell carcinomas, including cervical and head & neck cancer types.

PERFORMANCE

Limit of Quantitation (LoQ): 0.28 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume20 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4ASCC02GB CL SCC
4ASCC1BGB CL SCC-Control
4ASCC2BGB CL SCC-Calibrator

GB CL CA125

PRODUCT DESCRIPTION

This reagent is an in vitro quantitative assay using a sandwich chemiluminescent microparticle immunoassay format to measure CA-125 in human serum or plasma. It requires 10 µL sample and delivers results in approximately 10 minutes. The limit of quantification (LoQ) is 1.50 U/mL. Stored at 2-8°C, avoid direct sunlight and do not freeze. Used clinically as a tumor marker particularly for ovarian cancer diagnosis and monitoring.

PERFORMANCE

Limit of Quantitation (LoQ): 1.50 U/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume10 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationRUO

ORDERING INFORMATION

Catalogue No.Product
4ACA502GB CL CA125
4ACA51BGB CL CA125-Control
4ACA52BGB CL CA125-Calibrator

GB CL CA199

PRODUCT DESCRIPTION

The GB CL CA19-9 is an in vitro diagnostic quantitative chemiluminescent reagent kit designed for measuring carbohydrate antigen 19-9 (CA19-9) in human serum or plasma.

It applies a sandwich chemiluminescent immunoassay (CLIA) with magnetic microparticles, requiring only 10 µL of sample and providing results in 10 minutes. The limit of quantification (LoQ) is 1.80 U/mL, allowing rapid and reliable quantitation. Reagents must be stored at 2–8°C, protected from direct sunlight, and not frozen.

CA19-9 is an important tumor marker widely used as a tool in the diagnosis and monitoring of gastrointestinal cancers, particularly pancreatic, bile duct, gastric, and colorectal cancers.

PERFORMANCE

Limit of Quantitation (LoQ): 1.80 U/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume10 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationRUO

ORDERING INFORMATION

Catalogue No.Product
4ACA902GB CL CA19-9
4ACA91BGB CL CA19-9-Control
4ACA92BGB CL CA19-9-Calibrator